Avidity Biosciences, Inc.
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
Last updated:
Abstract:
Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.
Status:
Grant
Type:
Utility
Filling date:
31 Aug 2021
Issue date:
2 Aug 2022